Paul Tudor Jones Says No Chance Warsh Could Push Fed to Cut Rates Fanatics Secures FIFA Exclusive Collectibles License Deepening Sports Memorabilia Dominance Sensex Surges Over 850 Points Nifty Approaches 24000 as IranUS Deal Hopes Drive Crude Oil Plunge Richard Childress Racing Retires No 8 in Kyle Buschs Honor With Son Brexton Poised to Revive It Shein Acquires Everlane A New Chapter for Ethical Fashion and Fast Fashion Oil Prices Rise as Trump Issues Fresh Warning to Iran United Maritime Corporation USEA Q1 2026 Earnings Stellar EPS Beat Lifts Investor Sentiment RGR Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Uptick VBNK Q1 2026 Earnings VersaBank Posts BottomLine Miss as Interest Income Pressures Persist MUFG Q1 2026 Earnings Strong EPS Surprise of 397 Despite Stock Dip VRME Q4 2025 Earnings EPS Misses Estimates as Loss Per Share Widens NEWTI Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed Brookfield Property Partners 625 Preferred BPYPM Holds Steady at 1739 as Income Investors Eye Yield Chatham Lodging Trust CLDT Gains 187 as Hotel REIT Tests Key Resistance BEPI Holds Steady Near Midpoint of Key Range Brookfield BRP Holdings Perpetual Notes Flat at 1562 Murano Global Investments Warrants MRNOW Hold Steady at 004 as Trading Remains RangeBound KKR Income Opportunities Fund KIO Edges Higher on Steady Demand for Income Assets Microsoft and Anthropic in Early Talks for Custom AI Chip Deal Following 5 Billion Investment BBWI Q1 2026 Earnings EPS Surges Past Estimates with 1328 Surprise Scinai Immunotherapeutics SCNI Declines 725 Eyes Key Support at 043 Sportradar SRAD Edges Lower Amid Consolidation Key Levels to Watch SMX Security Matters Stock Plunges Nearly 10 as Selling Pressure Intensifies Johnson Controls International JCI Rallies 213 as Support Holds Eyes Resistance at 14528 Bold Eagle Acquisition Corp BEAG Holds Steady Near Support A Quiet Moment for a Special Purpose Acquisition Vehicle Bold Eagle Acquisition Corp Right BEAGR Plunges 25 Key Support Tested at 020 AllianceBernstein AB Holds Steady Near 37 Amidst Modest Pullback Collegium Pharmaceutical COLL Holds Near Resistance After Slight Decline